Literature DB >> 27687944

Comparison of treatment outcomes for superficial digital flexor tendonitis in National Hunt racehorses.

S Witte1, C Dedman2, F Harriss3, G Kelly3, Y-M Chang4, T H Witte5.   

Abstract

Superficial digital flexor (SDF) tendonitis is a common injury in Thoroughbred racehorses. Injuries require prolonged rehabilitation, with unpredictable outcomes and a high incidence of re-injury. This observational case-control study aimed to compare race outcomes after commonly advocated treatments for tendon healing. Clinical and racing records were evaluated for 127 National Hunt racehorses treated between 2007 and 2011 for an SDF tendon injury. Two age- and sex-matched control horses were selected for each case horse to analyse the effect on post-injury racing outcomes of pre-injury data, lesion severity and treatment group [controlled exercise alone, bar firing, intralesional platelet-rich plasma (PRP), tendon splitting, tendon splitting combined with bar firing]. Control horses raced more often than case horses, with higher maximum racing post rating (RPRmax) and longer racing distances. Pre-injury racing performance was not associated with treatment group. Rate of return to racing was not associated with lesion severity or treatment group. Number of races, total distance raced post-injury and RPRmax were not associated with lesion severity or treatment group. Controlled exercise alone offered similar post-injury racing outcomes in National Hunt racehorses with SDF tendonitis to the other treatment options examined. Bar firing, either alone or in conjunction with tendon splitting, provided no additional benefit in rate of return to racing and race performance.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Controlled exercise; Firing; PRP; Splitting

Mesh:

Year:  2016        PMID: 27687944     DOI: 10.1016/j.tvjl.2016.08.003

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  5 in total

1.  Randomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses.

Authors:  Sandrine Jacquet-Guibon; Anne-Gaelle Dupays; Virginie Coudry; Nathalie Crevier-Denoix; Sandrine Leroy; Fernando Siñeriz; Franck Chiappini; Denis Barritault; Jean-Marie Denoix
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

Review 2.  Learning from Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal Large Tissue Defects.

Authors:  Ranieri Cancedda; Sveva Bollini; Fiorella Descalzi; Maddalena Mastrogiacomo; Roberta Tasso
Journal:  Front Bioeng Biotechnol       Date:  2017-04-28

3.  Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses.

Authors:  Milomir Kovac; Yaroslav A Litvin; Ruslan O Aliev; Elena Y Zakirova; Catrin S Rutland; Andrey P Kiyasov; Albert A Rizvanov
Journal:  Front Pharmacol       Date:  2018-08-31       Impact factor: 5.810

Review 4.  A Critical Overview of the Use of Platelet-Rich Plasma in Equine Medicine Over the Last Decade.

Authors:  Livia Camargo Garbin; Catalina Lopez; Jorge U Carmona
Journal:  Front Vet Sci       Date:  2021-03-31

Review 5.  Role of Mechanical Loading for Platelet-Rich Plasma-Treated Achilles Tendinopathy.

Authors:  Alyssa Neph; Allison Schroeder; Keelen R Enseki; Peter A Everts; James H-C Wang; Kentaro Onishi
Journal:  Curr Sports Med Rep       Date:  2020-06       Impact factor: 1.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.